Featured Story

UC Davis becomes key player in stem cell research via The Sacramento Bee

May 24, 2015

Drs. Roslyn Rivkah, a professor of dermatology, and Jan Nolta, Director of the Stem Cell Program at UC Davis School of Medicine and the new Institute for Regenerative Cures, receive $5 million to develop a wound dressing that can be applied to chronic wounds such as diabetic foot ulcers, which afflict 6 million people nationally.

January 2016 arrow

Researchers decipher stem cell messages in blood vessel formation

January 26, 2016

Findings may lead to novel treatment approaches for peripheral artery disease

An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells. The findings, posted online today in the journal Stem Cells, will help scientists develop new stem cell-based treatment options for peripheral artery disease, a condition which affects about 12 million people in the United States alone.

American Academy of Neurology recognizes UC Davis Huntington's disease researcher

January 13, 2016

UC Davis’ leadership in Huntington’s disease research received another boost recently when Kyle Fink, a post-doctoral fellow at the Institute for Regenerative Cures, was recognized by the American Academy of Neurology (AAN) for the cutting-edge research findings in gene editing that he presented at the 2015 Society for Neuroscience Annual Meeting.

More research needed on evaluation of dense breasts

January 11, 2016

A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next. The study also found that supplemental diagnostic screenings for women with dense breasts find additional breast cancers but also greatly increase false positive results.

Left ventricular assist device program at UC Davis receives certification

January 7, 2015

UC Davis Medical Center has earned certification from The Joint Commission for its left ventricular assist device (LVAD) program, which offers a technological approach to treating advanced heart failure.

The LVAD is a mechanical pump that takes over some of the work of the heart, restoring blood flow and oxygen levels. The device is surgically implanted below the diaphragm and attached to the left ventricle and aorta, and then powered by two external batteries carried in underarm holsters or waist packs.

It takes a UC village: Smoking cessation push goes high tech

January 4, 2015

The program aims to simplify and streamline what should be routine preventive health care, but too often is neglected by providers. It began as a pilot project at UC Davis through a grant from the UC’s Center for Health Quality and Innovation and led by UC Davis internal medicine physician and tobacco control researcher Elisa Tong. The university later expanded the program across the entire system.

 

December 2015arrow

Two UC Davis experts among speakers at World Stem Cell Summit

December 9, 2015

Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.

Jan Nolta and Paul Knoepfler will be joining more than 1,200 other stem cell experts, including bioethicists, government regulators, patient advocates and investors from 40 countries, as they gather to discuss the discoveries and latest developments in regenerative medicine.

 

November 2015arrow

UC Davis Medical Center recognized for leadership in pulmonary rehabilitation

November 18, 2015

The Pulmonary Rehabilitation Program at UC Davis Medical Center has been certified by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) for leadership in improving health and quality of life for people with chronic obstructive pulmonary disease (COPD) and other lung diseases.

New technology will help define the environmental triggers of childhood asthma

November 5, 2015

UC Davis researchers have received a four-year, $1.5 million grant from the National Institutes of Health (NIH) to develop a small, wearable sensor that can measure the relationship between environmental exposures and pediatric asthma.

Kelly takes the reins of prestigious SWOG Lung Committee

November 4, 2015

Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.

 

October 2015arrow

October 7, 2015

Nicholas Kenyon, a nationally recognized expert in obstructive airway disease, has been appointed chief of the Division of Pulmonary, Critical Care and Sleep Medicine and the Gordon A. Wong Professor in Pulmonary and Critical Care Medicine at UC Davis Health System.

 

September 2015arrow

September 29, 2015

In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.

 

August 2015arrow

 August 20, 2015 

New York Blood Center (NYBC) [has] announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

 August 13, 2015

Two UC Davis School of Medicine faculty members and a dean emeritus of the school have been recognized with the 2015 Hibbard Williams Extraordinary Achievement Award and the C. John Tupper Prize for Excellence in Teaching. 

 August 13, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer. In early proof-of-concept research, the team took bladder tumors from individual patients, identified actionable mutations and grafted the tumors into mice. From there, the researchers simultaneously tested multiple therapies in the tumor models. Treatments that were effective in the models could then be given to patients. The research was published today in the journal PLoS One. 

 

May 2015arrow

May 26, 2015

A drug often prescribed to prevent or stall the progress of heart disease may also relieve symptoms of asthma, according to a new study from pulmonary medicine specialists at UC Davis Health System.

UC Davis UC Davis 6th Annual Lung Research Day pdf

May 5, 2015

Save the Date for the UC Davis 6th Annual Lung Research Day

Friday, June 19, 2015

"Asthma: Signals for the Future"  pdf

 

April 2015arrow

 Congratulations Dr. Carroll Cross, recipient of the Internal Medicine Career Achievement Award!

April 20, 2015

Dr. Cross is an outstanding mentor to many faculty in the division of Pulmonary/Critical Care Medicine even after year 40 as faculty.  He has been our translational research leader for decades, long before the term was defined. Dr. Cross’ career long expertise has been in the fields of cystic fibrosis (CF), alpha-1 antitrypsin (A1AT) deficiency, and the generation and function of reactive oxygen species in the lung.

Congratulations Dr. Cross!

 Congratulations Dr. Valentina Medici, recipient of the 2015 Internal Medicine Faculty Research Award!

April 20, 2015

After her graduation summa cum laude with the MD degree from the prestigious University of Padova in 2000 and subsequent fellowship training in Gastroenterology and Hepatology in Germany, Dr. Medici returned to the University of Padova where she began her research on the pathogenesis and management of Wilson disease (WD). This resulted in 8 publications of which she was first author on 5, that were clinical except for 3 that involved rat models of hepatic copper overload. Subsequently she moved to our institution in 2006 to become a visiting Assistant Professor and K30 scholar in our Mentored Clinical Scientist Development Award. Her subsequent research has focused on two areas of alcoholic liver disease (ALD) and WD.

Congratulations Dr. Medici!

 

March 2015arrow

Congratulations Dr. Tonya Fancher

March 6, 2015

Congratulations Dr. Tonya Fancher!  Dr. Fancher is the recipient of the 2014-2015 Chancellor's Achievement Award for Diversity and Community.

 

August 2014arrow

Congratulations Dr. Sanket Dhruva!

August 6, 2014

Sanket Dhruva, M.D. (PGY-6, cardiology) was recently accepted to become a Robert Wood Johnson Clinical Scholar at Yale University from 2015-2017. During medical school and internal medicine residency training at UCSF, he studied FDA regulation and Medicare coverage of medical devices. His work has been published in the New England Journal of Medicine, JAMA, and the British Medical Journal. During his cardiology fellowship at UC Davis, he has gained a better understanding of how devices are used to better the health of patients with cardiovascular disease and hopes to use the two-year clinical scholars program as a transition to an academic career.

 

July 2014arrow

Congratulations to the Division of Cardiovascular Medicine

July 24, 2014

  • Nipavan Chiamvimonvat, M.D. received a VA Merit Review Award, "Regulation of ion channels in the heart." Project Period: 10/01/2014 - 09/30/2018; Amount: $650,000
  • Javier Lopez, M.D. received a K12 award, “Predicting cardiac recovery after myocardial infarction: building a new quantitative EMR-based and microRNA expression prediction model” funded through CTSC. Project Period: 07/01/14 - 06/30/16; Amount: $200,000
  • Ye Chen-Izu, Ph.D. is the recipient of the Grant-in-Aid “Mechano-chemotransduction underlying mechanical stress induced arrhythmias,” from the American Heart Association (AHA) Project Period: 07/01/14 - 06/30/16 $140,000
  • Xiaodong Zhang, Ph.D. was awarded the Beginning Grant in Aid “Novel mechanisms for the regulation of acid –base balance in cardiac myocytesin" from the American Heart Association (AHA). Project Period: 01/01/14 - 12/31/15; Amount: $140,000
  • John Rutledge, M.D. received an Opportunity Grant “Assessment of cognitive function in mouse metabolic models” through the NIH-sponsored National Mouse Metabolic Phenotypic Center (MMPC). Project Period: 2014 - 2015; Amount: $162,000
  • The NIH T32 grant "Training Program in Basic and Translational Cardiovascular Sciences" has been renewed for another five years. Co-Program Directors: Nipavan Chiamvimonvat, M.D. and Ann Knowlton, M.D.  Project Period: 07/01/2013 - 06/30/2018; Amount: $2,050,000
  • Nipavan Chiamvimonvat, M.D. was the recipient of a NIH S10 Shared Equipment Grant "In vivo ultrasound imaging system," (VisualSonics Vevo2100).  Amount: $400,000
  • Nipavan Chiamvimonvat, M.D. published a paper "Functional interaction with filamin A and intracellular Ca2+ enhance the surface membrane expression of a small-conductance Ca2+-activated K+ (SK2) channel" in Proceedings of the National Academy of Sciences (PNAS). Click on the link to view the article http://www.pnas.org/content/111/27/9989.full.pdf+html
  • Ann Knowlton, M.D. received the 2013 Albrecht Fleckenstein Memorial Award for her distinguished work in the field of basic research from the International Academy of Cardiology.  Click on the link to view press release https://www.ucdmc.ucdavis.edu/publish/awards/aboutus/8081/?p=index.html